Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Andrew A. House(Western University), Stefan Störk(Berlin-Brandenburger Centrum für Regenerative Therapien), Peter A. McCullough(Parkland Foundation), Ali K. Abu‐Alfa(Yale University), Krista L. Lentine(Saint Louis University Hospital), George L. Bakris(Pennsylvania State System of Higher Education), Maria Rosa Costanzo(National Heart Foundation of Australia), Eisei Noiri(BioBank Japan), Wolfgang C. Winkelmayer(Palo Alto University), John G.F. Cleland(University of Glasgow), Biykem Bozkurt(Baylor College of Medicine), Christopher T. Chan(University Health Network), Patrick Rossignol(Inserm), Gerasimos Filippatos(National and Kapodistrian University of Athens), Christopher W. McIntyre(Western University), Betty Muthoni Gikonyo, Soko Setoguchi(Rutgers, The State University of New Jersey), Anita Deswal(The University of Texas MD Anderson Cancer Center), Hideki Ishii(Gunma University), Colin Baigent(University of Oxford), Roger J. Hajjar(Boston Biomedical Research Institute), Christoph Wanner(Universitätsklinikum Würzburg), John Boletis(National and Kapodistrian University of Athens), Manish M. Sood(Ottawa Hospital), Roberto Pecoits‐Filho(Pontifícia Universidade Católica do Paraná), Alberto Palazzuoli, Patrick B. Mark(Queen Elizabeth University Hospital), Bertram Pitt(Bayer (Germany)), Ileana L. Piña(American Heart Association), Greg Knoll(Ottawa Hospital), Etienne Macedo(University of California San Diego Medical Center), Lawrence J. Appel(Johns Hopkins University), Michael Cheung(National Kidney Foundation), Kerstin Amann(Friedrich-Alexander-Universität Erlangen-Nürnberg), David C. Wheeler(University College London), Christopher R. deFilippi, Charles A. Herzog, Paul Komenda(Seven Oaks General Hospital), Mark J. Sarnak(Tufts Medical Center), Kazutaka Aonuma(Mito Saiseikai General Hospital), Javed Butler(Saint Luke's Health System), Colin R. Lenihan, Debasish Banerjee(Toyota Motor Corporation (Switzerland)), Bertram L. Kasiske(University of Minnesota), Claudio Rigatto, Stefan D. Anker(Charité - Universitätsmedizin Berlin), Kunitoshi Iseki, Edgar V. Lerma, Dan Gikonyo, Ruth F. Dubin
Cited by 435
Related Papers
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
|Hypertension|2003|13.3k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k